Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · November 21, 2023

Anti-PSMA Monoclonal Antibody Radiolabeled With an Alpha Emitter for Metastatic Castration-Resistant Prostate Cancer

Journal of Clinical Oncology


Additional Info

Journal of Clinical Oncology
Prostate-Specific Membrane Antigen-Targeting Alpha Emitter via Antibody Delivery for Metastatic Castration-Resistant Prostate Cancer: A Phase I Dose-Escalation Study of 225Ac-J591
J. Clin. Oncol 2023 Nov 03;[EPub Ahead of Print], ST Tagawa, C Thomas, AO Sartor, M Sun, J Stangl-Kremser, M Bissassar, S Vallabhajosula, SH Castellanos, JT Nauseef, CN Sternberg, A Molina, K Ballman, DM Nanus, JR Osborne, NH Bander

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading